NeuroBioMat
Clinical Indication
Technology
About
Investors
News & Media
Contact
More
Use tab to navigate through the menu items.
Profile
Join date: May 4, 2021
Posts
Apr 22, 2022
∙
1 min
SPINEREP granted "Breakthrough Device Designation” by the U.S. Food and Drug Administration
NeuroBioMat's polymer medical device, SPINEREP, which is indicated to treat traumatic non-penetration spinal cord injury, has been...
0
0
Oct 25, 2021
∙
1 min
NeuroBioMat Makes Headlines in French Economic Magazine, Challenges
NEUROBIOMAT: A NEUROTECHNOLOGY TO REPAIR THE SPINAL CORD Read more... NEUROBIOMAT : UNE NEUROTECHNOLOGIE POUR RÉPARER LA MOELLE ÉPINIÈRE...
6
0
Caroline Sagrada
Admin
0
Followers
0
Following
Follow
Following icon
More actions
Profile
More
Use tab to navigate through the menu items.